MedTrace Logo

Evaluation and Optimization of Hearing Devices in 3-D Complex Audio Environments Study 2

NCT03774030 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-05-09

No results posted yet for this study

Summary

A methodical evaluation of novel sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired participants. These sound changing principles are enabled by respective hearing instrument technologies and hearing instrument algorithms. The aim of the study is to investigate and assess strengths and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Both, objective laboratory measurements as well as subjective evaluations in real life environment will be carried out. This will be a controlled, single blinded and randomised active comparator clinical evaluation which will be conducted mono centric at the University Hospital of Zürich.

Conditions

  • Ability, Spatial

Interventions

PROCEDURE

several virtual 3-D complex audio environments

The focus is a comparison of 3 hearing aid algorithms in a virtual 3-D complex audio Environment.

Sponsors & Collaborators

  • Swiss Commission for Technology and Innovation

    collaborator OTHER

  • Sonova AG

    lead INDUSTRY

Principal Investigators

  • Norbert Dillier, Professor · University Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-09
Primary Completion
2019-01-21
Completion
2019-01-21

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03774030 on ClinicalTrials.gov